Rialto Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Buy
233
+3
+1% +$3.54K 0.05% 151
2026
Q2
$276K Sell
230
-4
-2% -$4.09K 0.05% 147
2026
Q1
$216K Sell
234
-43
-16% -$43.6K 0.05% 155
2025
Q4
$298K Buy
277
+119
+75% +$114K 0.07% 128
2025
Q3
$121K Sell
158
-8
-5% -$5.95K 0.03% 185
2025
Q2
$130K Sell
166
-1
-0.6% -$777 0.04% 176
2025
Q1
$138K Buy
167
+11
+7% +$9.15K 0.04% 169
2024
Q4
$121K Buy
+156
New +$129K 0.04% 182

Other funds holding LLY

Rialto Wealth Management's LLY Position: Q3 2026 in Review

Rialto Wealth Management increased its Eli Lilly (LLY) stake by 1.3% in Q3 2026, buying an estimated $3.54K and bringing the position to 233 shares worth $270K. The position accounts for 0.05% of the portfolio, ranked #151.

Rialto Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $298K in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Rialto Wealth Management held 233 shares of Eli Lilly worth $270K as of Q3 2026.
  • Rialto Wealth Management bought 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.05% of Rialto Wealth Management's portfolio in Q3 2026, its #151 holding.
  • Rialto Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Rialto Wealth Management's Eli Lilly position peaked at $298K in Q4 2025.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.